Fischer Medical Ventures Regulatory Approval
Fischer Medical Ventures secured CDSCO regulatory clearance to import and distribute the Spincare Portable Wound Care System. This marks India's first approval for a portable electrospun wound system.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
40 announcements with these filters
Fischer Medical Ventures secured CDSCO regulatory clearance to import and distribute the Spincare Portable Wound Care System. This marks India's first approval for a portable electrospun wound system.
Fischer Medical Ventures responded to NSE queries regarding segment details and submission delays for its financial results. The company cited technical issues with the NEAPS portal.
Fischer Medical Ventures Ltd submitted a Reg 74(5) compliance certificate confirming dematerialisation of securities for Q1‑2026. The filing updates the exchange records.
Fischer Medical Ventures Ltd reported revenue from operations of ₹101.1 Cr (+105.5% YoY) and net profit of ₹19.2 Cr (+1376.9% YoY) for Q4 FY26.
Fischer Medical Ventures reported audited FY26 results and recommended a ₹0.05 per share dividend. The board also re-appointed S. Ramanand Aiyer & Co. as internal auditors.
Fischer Medical Ventures recommended a 5% final dividend for financial year 2025-26. Pending shareholder approval, the Rs. 0.05 per share payout reward current investors.
Fischer Medical Ventures Ltd reported revenue from operations of ₹97.7 Cr (+98.6% YoY) and a net loss of ₹7.1 Cr for Q4 FY26.
Fischer Medical Ventures reported audited FY26 results and recommended a Rs. 0.05 per share final dividend. The board also appointed S. Ramanand Aiyer & Co as internal auditors.
Fischer Medical Ventures scheduled a board meeting for May 29, 2026. Directors will consider FY26 audited financial results and potential dividend recommendations.
Fischer Medical subsidiary Time Medical India partnered with the WFNS Innovation Committee. This landmark collaboration focuses on advanced neurosurgical imaging and global medical technology training.